Developer docs
API playgroundTry for free, no card

Search company profiles

NoyMed

Full company profile

uuid000n3fq

Namestring
NoyMed
Legal namestring
NoyMed
Websiteurl
noymed.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

NoyMed is a privately held Contract Research Organization (CRO) founded in 2017 with headquarters in Glendale, California and execution offices in Yerevan and Vanadzor, Armenia. The company positions itself as a niche biometrics CRO with full clinical operations (ClinOps) capabilities, supporting Phase I-IV clinical trials for pharmaceutical, biotechnology, medical device companies, and research institutes globally. Its service portfolio spans Biostatistics with PK/PD analysis, Statistical Programming (SAS) with CDISC conversion (SDTM/ADaM, CDASH, Define.xml), end-to-end Data Management, Clinical Operations, Medical Writing, and Pharmacovigilance.

Underlying technology centers on SAS programming with CDISC regulatory standards and a partner relationship with the TrialKit EDC platform, which the company describes as supporting over 8,000 studies globally with web, mobile, and wearable-based remote data capture. NoyMed also claims an adaptive clinical trial design methodology delivering a 25-35% efficiency uplift and a 2-week turnaround from database lock to data analysis and review (4 weeks faster than industry average).

NoyMed operates a project-based professional services revenue model with custom quote-based pricing and multi-year contracts. Go-to-market is enterprise direct sales targeting pharmaceutical, biotechnology, medical device, and research institute buyers, executed through the website's "Request a Quote" flow and direct email. Distribution leverages multi-timezone coverage across US and Armenia offices. The company is owned by three co-founders — Armen Margaryan (CEO), Ani Markosyan (CSO), and Tatevik Simonyan — with no disclosed external institutional investors or funding rounds. Therapeutic-area exposure spans oncology (16.5% of recent mix), neurology/CNS, cardiovascular, dermatology, metabolic disease, anti-infective, ophthalmology, allergy/respiratory, gastroenterology, anti-inflammatory, vaccine, and immunology. (Note: firmographic data lists a 2012 founding year, while the company-history timeline records 2017 — 2017 is used as the more specific reference.)

Short descriptiontext

NoyMed is a privately held niche biometrics CRO with full clinical operations capabilities, providing Phase I-IV biostatistics, SAS/CDISC programming, data management, medical writing, and pharmacovigilance services to pharmaceutical, biotechnology, medical device companies and research institutes globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGlendale, United States
HQ citystring
Glendale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, biometrics CRO, clinical data management, pharmacovigilance services, biostatistics programming
Industry2 codes
PRIMARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Research Services
TypeProfessional Services
Description

Full-service CRO providing end-to-end clinical trial solutions including biometrics, clinical operations, pharmacovigilance, and medical writing services to pharmaceutical, biotech, and medical device companies. Revenue generated through project-based contracts and service agreements.

noymed.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed

noymed.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NoyMed is a Contract Research Organization (CRO) providing biometrics and clinical operations services to pharmaceutical, biotechnology, and medical device companies. Its services include biostatistics and PK/PD analysis, SAS statistical programming with CDISC-compliant datasets, full data management on the TrialKit EDC platform, end-to-end clinical trial operations, medical writing, and pharmacovigilance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 95% customer retention rate over a decade of experience working on 170+ trials
+2 more records
Product overview1 text field

NoyMed is a niche Biometrics CRO providing a comprehensive suite of clinical trial services alongside its proprietary TrialKit EDC platform. The service portfolio includes Biostatistics-PK/PD Analysis, Statistical Programming (SAS/CDISC), Full Data Management, End to End Clinical Operations, Medical Writing, and Pharmacovigilance. These services work together to provide sponsors with end-to-end clinical trial support from Phase I-IV, with TrialKit serving as the underlying EDC technology enabling data collection across the service offerings.

Product and service6 records
1Biostatistics-PK/PD Analysis
CategoryBiostatistics
2Statistical Programming Services
CategoryStatistical Programming
3Full Data Management
4End to End Clinical Operations
CategoryClinical Operations
5Medical Writing
CategoryMedical Writing
6Pharmacovigilance
CategoryPharmacovigilance
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-size global CRO with strong biometrics and clinical operations capabilities serving biotech and pharma sponsors. Comparable in positioning as a science-focused mid-market CRO, though materially larger and publicly traded; relevant as a benchmark for NoyMed's potential scale-up trajectory.

TypeBroad incumbent
Description

Large global CRO offering full-service clinical trial, biometrics, and pharmacovigilance solutions to pharma and biotech. Comparable service overlap, though at significantly larger scale and with broader geographic coverage.

TypeBroad incumbent
Description

One of the world's largest CROs offering full-service clinical, biometrics, and pharmacovigilance capabilities globally. Represents the tier of incumbents NoyMed competes against for large enterprise deals.

TypeBroad incumbent
Description

Largest global CRO/biopharma services firm with end-to-end biometrics, clinical operations, and real-world evidence capabilities. Relevant as the dominant incumbent setting industry benchmarks and pricing.

TypeDirect peer
Description

Mid-tier global CRO offering biometrics, clinical operations, and pharmacovigilance to pharma and biotech. Comparable size and service mix to NoyMed, particularly in biometrics-heavy Phase II/III work.

TypeDirect peer
Description

Privately held global CRO with strong biometrics, data management, and full-service clinical operations. Comparable mid-tier private CRO profile and multi-geography delivery model.

TypeBroad incumbent
Description

Large life-sciences services firm with significant CRO and biometrics offerings. Comparable service categories (biostatistics, data management, pharmacovigilance) but operates at vastly greater scale.

TypeDirect peer
Description

Mid-sized CRO (now part of Syneos) offering biometrics, data management, and full-service clinical trial support to biotech and pharma. Similar size, service breadth, and sponsor mix to NoyMed.

TypeDirect peer
Description

Mid-sized CRO with deep biometrics, clinical operations, and medical writing capabilities focused on biotech and specialty pharma. Directly comparable in scale, therapeutic breadth, and biometrics-led positioning.

TypeEmerging player
Description

Asia-Pacific-headquartered CRO with growing global biometrics and clinical operations footprint. Comparable as a mid-sized, growth-oriented CRO competing for biotech sponsors, with similar cost-arbitrage delivery model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NoyMed

Contract Research Organization (CRO) Servicesnoymed.com

NoyMed is a privately held niche biometrics CRO with full clinical operations capabilities, providing Phase I-IV biostatistics, SAS/CDISC programming, data management, medical writing, and pharmacovigilance services to pharmaceutical, biotechnology, medical device companies and research institutes globally.

What NoyMed does

NoyMed is a privately held Contract Research Organization (CRO) founded in 2017 with headquarters in Glendale, California and execution offices in Yerevan and Vanadzor, Armenia. The company positions itself as a niche biometrics CRO with full clinical operations (ClinOps) capabilities, supporting Phase I-IV clinical trials for pharmaceutical, biotechnology, medical device companies, and research institutes globally. Its service portfolio spans Biostatistics with PK/PD analysis, Statistical Programming (SAS) with CDISC conversion (SDTM/ADaM, CDASH, Define.xml), end-to-end Data Management, Clinical Operations, Medical Writing, and Pharmacovigilance.

Underlying technology centers on SAS programming with CDISC regulatory standards and a partner relationship with the TrialKit EDC platform, which the company describes as supporting over 8,000 studies globally with web, mobile, and wearable-based remote data capture. NoyMed also claims an adaptive clinical trial design methodology delivering a 25-35% efficiency uplift and a 2-week turnaround from database lock to data analysis and review (4 weeks faster than industry average).

NoyMed operates a project-based professional services revenue model with custom quote-based pricing and multi-year contracts. Go-to-market is enterprise direct sales targeting pharmaceutical, biotechnology, medical device, and research institute buyers, executed through the website's "Request a Quote" flow and direct email. Distribution leverages multi-timezone coverage across US and Armenia offices. The company is owned by three co-founders — Armen Margaryan (CEO), Ani Markosyan (CSO), and Tatevik Simonyan — with no disclosed external institutional investors or funding rounds. Therapeutic-area exposure spans oncology (16.5% of recent mix), neurology/CNS, cardiovascular, dermatology, metabolic disease, anti-infective, ophthalmology, allergy/respiratory, gastroenterology, anti-inflammatory, vaccine, and immunology. (Note: firmographic data lists a 2012 founding year, while the company-history timeline records 2017 — 2017 is used as the more specific reference.)

NoyMed firmographics

Firmographics
Name
NoyMed
Legal name
NoyMed
Website
https://noymed.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
NoyMed is a privately held niche biometrics CRO with full clinical operations capabilities, providing Phase I-IV biostatistics, SAS/CDISC programming, data management, medical writing, and pharmacovigilance services to pharmaceutical, biotechnology, medical device companies and research institutes globally.
Ownership category
akta.pro rank

NoyMed industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs

Keywords

  • Clinical research services
  • Biometrics CRO
  • Clinical data management
  • Pharmacovigilance services
  • Biostatistics programming

Where NoyMed is headquartered

Location

Headquarters

HQ city
Glendale
HQ country
United States
HQ region
North America

Offices3 records

Markets served

NoyMed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Research Services: Full-service CRO providing end-to-end clinical trial solutions including biometrics, clinical operations, pharmacovigilance, and medical writing services to pharmaceutical, biotech, and medical device companies. Revenue generated through project-based contracts and service agreements.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

NoyMed product offering

Product offering

Core offering

NoyMed is a Contract Research Organization (CRO) providing biometrics and clinical operations services to pharmaceutical, biotechnology, and medical device companies. Its services include biostatistics and PK/PD analysis, SAS statistical programming with CDISC-compliant datasets, full data management on the TrialKit EDC platform, end-to-end clinical trial operations, medical writing, and pharmacovigilance.

Product overview

NoyMed is a niche Biometrics CRO providing a comprehensive suite of clinical trial services alongside its proprietary TrialKit EDC platform. The service portfolio includes Biostatistics-PK/PD Analysis, Statistical Programming (SAS/CDISC), Full Data Management, End to End Clinical Operations, Medical Writing, and Pharmacovigilance. These services work together to provide sponsors with end-to-end clinical trial support from Phase I-IV, with TrialKit serving as the underlying EDC technology enabling data collection across the service offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biostatistics-PK/PD Analysis
  • Statistical Programming Services
  • Full Data Management
  • End to End Clinical Operations
  • Medical Writing
  • Pharmacovigilance

Quantifiable outcome

  • 95% customer retention rate over a decade of experience working on 170+ trials
  • +2 more outcomes

Companies that use NoyMed

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles1 record

NoyMed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

NoyMed partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

NoyMed competitors and assessment

Company assessment

Direct peers

  • Medpace: Mid-size global CRO with strong biometrics and clinical operations capabilities serving biotech and pharma sponsors. Comparable in positioning as a science-focused mid-market CRO, though materially larger and publicly traded; relevant as a benchmark for NoyMed's potential scale-up trajectory.
  • Worldwide Clinical Trials: Mid-tier global CRO offering biometrics, clinical operations, and pharmacovigilance to pharma and biotech. Comparable size and service mix to NoyMed, particularly in biometrics-heavy Phase II/III work.
  • PSI CRO: Privately held global CRO with strong biometrics, data management, and full-service clinical operations. Comparable mid-tier private CRO profile and multi-geography delivery model.
  • Synteract: Mid-sized CRO (now part of Syneos) offering biometrics, data management, and full-service clinical trial support to biotech and pharma. Similar size, service breadth, and sponsor mix to NoyMed.
  • Premier Research: Mid-sized CRO with deep biometrics, clinical operations, and medical writing capabilities focused on biotech and specialty pharma. Directly comparable in scale, therapeutic breadth, and biometrics-led positioning.

Broad incumbents

  • Parexel: Large global CRO offering full-service clinical trial, biometrics, and pharmacovigilance solutions to pharma and biotech. Comparable service overlap, though at significantly larger scale and with broader geographic coverage.
  • ICON plc: One of the world's largest CROs offering full-service clinical, biometrics, and pharmacovigilance capabilities globally. Represents the tier of incumbents NoyMed competes against for large enterprise deals.
  • IQVIA: Largest global CRO/biopharma services firm with end-to-end biometrics, clinical operations, and real-world evidence capabilities. Relevant as the dominant incumbent setting industry benchmarks and pricing.
  • Charles River Laboratories: Large life-sciences services firm with significant CRO and biometrics offerings. Comparable service categories (biostatistics, data management, pharmacovigilance) but operates at vastly greater scale.

Emerging players

  • Novotech: Asia-Pacific-headquartered CRO with growing global biometrics and clinical operations footprint. Comparable as a mid-sized, growth-oriented CRO competing for biotech sponsors, with similar cost-arbitrage delivery model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

NoyMed social profiles

Digital presence

NoyMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NoyMed leadership team

Management profile

Number of profiles

Profiles3 records

NoyMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NoyMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NoyMed

What does NoyMed do?

NoyMed is a Contract Research Organization (CRO) providing biometrics and clinical operations services to pharmaceutical, biotechnology, and medical device companies. Its services include biostatistics and PK/PD analysis, SAS statistical programming with CDISC-compliant datasets, full data management on the TrialKit EDC platform, end-to-end clinical trial operations, medical writing, and pharmacovigilance.

Is NoyMed a public or private company?

NoyMed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NoyMed founded?

NoyMed was founded in 2017. It employs 101 to 250 people.

Where is NoyMed based?

NoyMed is headquartered in Glendale, United States, in the North America region.

How does NoyMed make money?

One revenue line is on record: clinical Research Services.

Who are NoyMed's main competitors?

Direct peers on record are Medpace, Worldwide Clinical Trials, PSI CRO, Synteract and Premier Research. Broad incumbents are Parexel, ICON plc, IQVIA and Charles River Laboratories. Novotech is listed as an emerging player.

Does NoyMed have an API?

No public API is recorded for NoyMed.

What industry is NoyMed in?

NoyMed's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales